APC and cancer: It functions via binding to the eukaryotic ribosome and thus, inhibiting protein synthesis A synthetic aminoglycoside derivative (NB124) was recently developed and shown to suppress premature termination codons in TP53 and APC in human cancer cells, and therefore, induce their apoptosis123.